Company intelligence / Profile preview

Circius Pharma

Ownership: Private
Development stage: Commercial

Overview

Commercial-stage company with established OTC products and ongoing post-market clinical follow-up studies. First-year revenue exceeded SEK100M (~$9M USD)

Therapeutic areas: OtherMetabolic DisordersInfectious Diseases
Modalities: Small molecules(Presumably) medical devices (ear spray, pressure equalization device)
Industry: Biotech

Drug pipeline

6 assets

Waxonova

Unknown

5 more assets in the full pipeline.

Request access →

Partnerships

academic collaborations

Beyond the preview

Go deeper on Circius Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Circius Pharma.

Explore the full profile